(Q72040807)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

lymphoblastic leukemia

1 reference

J R Priest

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

N K Ramsay

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

P G Steinherz

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

D G Tubergen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M S Cairo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A L Sitarz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A J Bishop

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

L White

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M E Trigg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

C J Levitt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J A Cich

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

P F Coccia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

language of work or name

English

0 references

publication date

1 June 1982

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

984-989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

L-asparaginase: clinical, biochemical, pharmacological, and immunological studies

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Toxicity of E. coli L-asparaginase in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Effect of L-asparaginase on carbohydrate metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Acute Deficiency of Thyroxine-Binding Globulin during L-Asparaginase Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

The effect of L-asparaginase of plasma coagulation factors in acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Reduced antithrombin III levels during L-asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Intracranial hemorrhage and focal seizures secondary to use of L-asparaginase during induction therapy of acute lymphocytic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Thrombotic and hemorrhagic strokes complicating early therapy for childhood acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Antithrombin III deficiency during asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

L-asparaginase, antithrombin III, and thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Antithrombin III deficiency during asparaginase therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Toxicity of L-asparaginase in children with advanced leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

Intensification of induction therapy of acute lymphoblastic leukemia with L-asparaginase in children. Results of a 5-year randomised study (author's transl)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2882%2980535-0

10.1016/S0022-3476(82)80535-0

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6953221%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference